Acceptability of the oral hormonal male contraceptive prototype, 11β-Methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trial.
Sign Up to like & getrecommendations! Published in 2021 at "Contraception"
DOI: 10.1016/j.contraception.2021.06.009
Abstract: OBJECTIVE To determine men's satisfaction with and the potential acceptability of 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC) when used for 28 days as an experimental, once-daily, oral hormonal male contraceptive (HMC). STUDY DESIGN We surveyed participants from a… read more here.
Keywords: trial; nortestosterone dodecylcarbonate; dodecylcarbonate mntdc; hormonal male ... See more keywords